Badreddin Edris
Founder bij EDGEWISE THERAPEUTICS, INC.
Vermogen: 10 M $ op 31-03-2024
Profiel
Badreddin Edris was the founder of Silverback Therapeutics, Inc. (founded in 2016) where he held the title of Chief Business Officer from 2016 to 2018.
He is also the founder of Edgewise Therapeutics, Inc. (founded in 2017) where he currently serves as an Independent Non-Executive Director.
In addition to his founding positions, Dr. Edris is currently the Chief Operating Officer at Springworks Therapeutics, Inc. since 2018.
Previously, Dr. Edris held the position of Principal at Genentech Ventures, Inc. and Mission Bay Capital Management, Inc. He also worked as a Principal at OrbiMed Advisors LLC from 2014 to 2018.
Dr. Edris completed his education at Stanford University, earning a graduate degree in 2009.
He also obtained an undergraduate degree from Weber State University in 2007 and a doctorate degree from Stanford University School of Medicine in 2012.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 25-03-2024 | 195 629 ( 0.27% ) | 10 M $ | 31-03-2024 | |
| 12-06-2023 | 19 820 ( 0.02% ) | 361 517 $ | 31-03-2024 |
Actieve functies van Badreddin Edris
| Bedrijven | Functie | Begin |
|---|---|---|
| SPRINGWORKS THERAPEUTICS, INC. | Chief Operating Officer | 01-01-2021 |
| EDGEWISE THERAPEUTICS, INC. | Founder | 01-01-2017 |
Eerdere bekende functies van Badreddin Edris
| Bedrijven | Functie | Einde |
|---|---|---|
OrbiMed Advisors LLC
 OrbiMed Advisors LLC Investment ManagersFinance OrbiMed Advisors LLC is an independent, SEC-registered investment advisor and hedge fund manager headquartered in New York City. It was founded by Sven Borho and Carl Gordon in 1989. The firm provides discretionary investment management services to US and non-US public and private funds. | Corporate Officer/Principal | 01-11-2018 |
| ARS PHARMACEUTICALS, INC. | Founder | 01-09-2018 |
Mission Bay Capital Management, Inc.
 Mission Bay Capital Management, Inc. Investment ManagersFinance Mission Bay Capital Management Inc (Mission Bay Capital) is a venture capital firm founded in 2009. The firm is headquartered in San Francisco, California. | Corporate Officer/Principal | - |
Genentech Ventures, Inc.
 Genentech Ventures, Inc. Investment ManagersFinance Genentech Ventures (Genentech Ventures) is a venture capital firm founded in 1900. The firm is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - |
Opleiding van Badreddin Edris
| Stanford University | Graduate Degree |
| Weber State University | Undergraduate Degree |
| Stanford University School of Medicine | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| EDGEWISE THERAPEUTICS, INC. | Health Technology |
| SPRINGWORKS THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 4 |
|---|---|
OrbiMed Advisors LLC
OrbiMed Advisors LLC Investment ManagersFinance OrbiMed Advisors LLC is an independent, SEC-registered investment advisor and hedge fund manager headquartered in New York City. It was founded by Sven Borho and Carl Gordon in 1989. The firm provides discretionary investment management services to US and non-US public and private funds. | Finance |
Genentech Ventures, Inc.
Genentech Ventures, Inc. Investment ManagersFinance Genentech Ventures (Genentech Ventures) is a venture capital firm founded in 1900. The firm is headquartered in South San Francisco, CA. | Finance |
Mission Bay Capital Management, Inc.
Mission Bay Capital Management, Inc. Investment ManagersFinance Mission Bay Capital Management Inc (Mission Bay Capital) is a venture capital firm founded in 2009. The firm is headquartered in San Francisco, California. | Finance |
Silverback Therapeutics, Inc.
 Silverback Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Silverback Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on the proprietary ImmunoTAC technology platform to develop systemically delivered, tissue targeted therapeutics for the treatment of cancer, chronic viral infections, and other serious diseases. The company was founded by Peter A. Thompson January 4, 2016 and is headquartered in Seattle, WA. | Health Technology |
